Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Signet Ring Cell Carcinoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableStudy completedNCT06978595
What this trial is testing

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Who this might be right for
Colorectal CarcinomaCancerSignet Ring Adenocarcinoma of the Colon
asmaa salama ibrahim 8,171
Testing effectiveness (Phase 2)Looking for participantsNCT07629609
What this trial is testing

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Pancreatic Cancer, AdultGastroesophageal Cancer (GC)
Barbara Malene Fischer 90
Not applicableLooking for participantsNCT07769346
What this trial is testing

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

Who this might be right for
Appendix CancerPseudomyxoma Peritonei
Appendix Cancer Pseudomyxoma Peritonei Research Foundation 10,000
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Not applicableStudy completedNCT00633607
What this trial is testing

Hereditary Colorectal and Associated Tumor Registry Study

Who this might be right for
Lynch SyndromeFAPHereditary Diffuse Gastric Cancer+2 more
University of Pittsburgh 114
Not applicableStudy completedNCT01824966
What this trial is testing

Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma

Who this might be right for
AdenocarcinomaEsophageal Cancer
University Hospital, Gasthuisberg 82
Large-scale testing (Phase 3)Study completedNCT01226394
What this trial is testing

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients

Who this might be right for
Colorectal Cancer With a Resected Minimal Synchronous PCOvarian MetastasesTumour Rupture in the Abdominal Cavity
Gustave Roussy, Cancer Campus, Grand Paris 150
Not applicableStudy completedNCT03030404
What this trial is testing

Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer

Who this might be right for
Stomach NeoplasmsStomach CancerGastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)+2 more
National Cancer Institute (NCI) 733
Not applicableLooking for participantsNCT06726642
What this trial is testing

CfDNA in Hereditary And High-risk Malignancies 2

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,000
Not applicableStudy completedNCT01249859
What this trial is testing

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

Who this might be right for
Signet Ring Cell CarcinomaStomach DiseaseOesophagus+2 more
University Hospital, Lille 2,500
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Not applicableLooking for participantsNCT05126290
What this trial is testing

CTNNA1 Familial Expansion Study

Who this might be right for
Cancer Gene MutationGastric CancerBreast Cancer
Abramson Cancer Center at Penn Medicine 100
Testing effectiveness (Phase 2)Ended earlyNCT05001282
What this trial is testing

Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more
Elucida Oncology 79
Testing effectiveness (Phase 2)Looking for participantsNCT06371586
What this trial is testing

Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC

Who this might be right for
Gastric CancerDiffuse Type Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 67
Not applicableUnknownNCT05985577
What this trial is testing

Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics

Who this might be right for
Gastric CancerSignet Ring Cell Carcinoma
Zhejiang Cancer Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03620643
What this trial is testing

Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

Who this might be right for
Lobular Breast CarcinomaGastric CancerTriple Negative Breast Cancer+1 more
Royal Marsden NHS Foundation Trust 33
Not applicableStudy completedNCT01726296
What this trial is testing

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Who this might be right for
Adenocarcinoma of the LungMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+23 more
Fox Chase Cancer Center 1,440
Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT03648879
What this trial is testing

Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome

Who this might be right for
Gastric CancerGastric Neoplasms
National Cancer Institute (NCI) 37
Next Page